Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000526:Alprenolol / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010744:Phosphoric Monoester Hydrolases / Q000097:blood; D010919:Placebos; D011188:Potassium / Q000097:blood; D013943:Thymol / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001798:Blood Proteins; D006454:Hemoglobins; D010919:Placebos; D014280:Triglycerides; D013943:Thymol; D000526:Alprenolol; D005340:Fibrinogen; D002784:Cholesterol; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D010744:Phosphoric Monoester Hydrolases; D001663:Bilirubin; D011188:Potassium